Cognition Therapeutics Announces Participation in Sachs 6th Annual Neuroscience Forum, Biotech Showcase, and BIO Partnering @ JPM During “J.P. Morgan Week 2023”
PURCHASE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq:CGTX) (the “Company” or “Cognition”), announced today that the Company’s management team will participate in the 6th Annual Sachs Neuroscience Forum, Biotech Showcase and BIO Partnering @ JPM. All events will be held in-person and are scheduled alongside the J.P. Morgan 41st Annual Healthcare Conference 2023.
Related news for (CGTX)
- Breaking News: MoBot’s Latest Update as of 08/25/25 08:00 AM
- Breaking News: MoBot’s Latest Update as of 08/22/25 04:00 PM
- MoBot’s Stock Market Highlights – 08/22/25 03:00 PM
- MoBot alert highlights: NASDAQ: HTCR, NASDAQ: CGTX, NASDAQ: NXL, NASDAQ: ANTE, NASDAQ: MODV (08/22/25 12:00 PM)
- Today’s Top Performers: MoBot’s Market Review 08/20/25 03:00 PM